As the majority of epithelioid mesotheliomas demonstrate strong MUC1/epithelial membrane antigen (EMA) positivity by immunohistochemistry (Ordonez, 2003) similar anti-MUC1 therapeutic strategies may have potential in mesothelioma. Here, MUC1 is linked to malignant epithelioid mesothelioma.